Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celsion Corp (NASDAQ:CLSN)

0.6701
Delayed Data
As of Dec 09
 +0.0286 / +4.46%
Today’s Change
0.62
Today|||52-Week Range
2.05
-65.10%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$17.5M

Company Description

Celsion Corp. is an oncology drug development company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA- based therapies. Its products include Celsion, ThermoDox, EGEN, TheraPlas and TheraSilence. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Contact Information

Celsion Corp.
997 Lenox Drive
Lawrenceville New Jersey 08648
P:(609) 896-9100
Investor Relations:
(609) 482-2455

Employees

Shareholders

Other institutional9.45%
Mutual fund holders4.30%
Individual stakeholders11.33%

Top Executives

Michael H. TardugnoExecutive Chairman, President & CEO
Jeffrey Wayne ChurchCFO, Secretary & SVP-Investor Relations
Nicholas BorysChief Medical Officer & Vice President
Khursheed AnwerChief Scientific Officer & Executive VP
Jason FewellVice President-Preclinical Research